Siemens Healthineers has agreed to buy Corindus Vascular Robotics, the US developer of robotic-assisted vascular interventions, in a US$1.1bn deal. Siemens Medical Solutions, a subsidiary of the German health-tech business, will acquire Corindus at US$4.28 per share. This is a 77% premium to the US company’s closing share price on Wednesday. ‘We believe the transaction…
Home Healthcare Markets International Business US: Siemens Healthineers buys US robotics company for US$1.1bn